http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2063044-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40d2d8436b54c14754e57e3fba2ad74b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 1992-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad1a259cf0668529eb3b039bf0e1b2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5494d0dc92e21f721769aed1f35de39b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dce0b934072b0b80e87ba60050149fb |
| publicationDate | 1996-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2063044-C1 |
| titleOfInvention | Method of prognosis of infectious-allergic bronchial asthma course |
| abstract | FIELD: medicine, pulmonology. SUBSTANCE: regulation of glutathione transferase activity with cAMP is determined in blood erythrocytes. Enzyme activity is determined using 1-chloro-2,4-dinitrobenzene as substrate and activity is expressed as nmole/min/1 mg protein. Effect of cAMP is determined as an activity increase. In the absence of glutathione transferase regulation effect with cAMP phase of exacerbation disease and dispnea attacks were observed in patient that requires intensive broncholytic therapy application. Remission phase disease at favorable prognosis is diagnosed in the presence of glutathione transferase regulation with cAMP. EFFECT: increased precision, simplified analysis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2469329-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2458347-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2486870-C1 |
| priorityDate | 1992-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.